{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Synaptogenix, Inc.
Is Synaptogenix, Inc. technically bullish or bearish?
As of June 9, 2025, the trend is mildly bullish due to a bullish MACD and KST on weekly and monthly charts, despite some conflicting signals from daily moving averages and Bollinger Bands.
What does Synaptogenix, Inc. do?
Synaptogenix, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with a market cap of $5.45 million and no recent profits. Key financial metrics include a negative P/E ratio, a dividend yield of 0.00%, and a return on equity of -113.14%.
How big is Synaptogenix, Inc.?
As of Jun 18, Synaptogenix, Inc. has a market capitalization of 5.45 million, with net sales of 0.00 million and a net profit of -12.17 million over the latest four quarters. The company reported shareholder's funds of 5.86 million and total assets of 17.73 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
